Cite Filings / HRTX / 0001193125-26-196314
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
ARS

Annual Report to Security Holders

HERON THERAPEUTICS, INC. /DE/ · Filed 2026-04-30 · Acc 0001193125-26-196314

Documents 1

  • ARS Annual Report to Security Holders , hrtx_2026_ars_2025_10-k.pdf

Around this filing

  • 2026-05-04 4 EVP, Chief Development Officer acquired 23,464 shares (option exercise)
  • 2026-05-04 4 EVP, Chief Financial Officer acquired 25,229 shares (option exercise)
  • 2026-05-04 4 Chief Executive Officer acquired 84,810 shares (option exercise)
  • 2026-04-30 ARS Annual Report to Security Holders
  • 2026-04-30 DEFA14A Proxy Materials
  • 2026-04-30 DEF 14A Proxy Statement
  • 2025-04-30 ARS Annual Report to Security Holders

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading hrtx_2026_ars_2025_10-k.pdf…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…